Skip to main content
. 2021 Jun 24;36(4):473–481. doi: 10.46497/ArchRheumatol.2021.8364

Table 3. Nature and results of altered biological treatment course during COVID-19-related restriction period (n=277).

  n % Mean±SD
Continued medications      
Continued as it was before 178 64.3  
Stopped only biological and synthetic therapy 22 7.9  
Decreased or skipped the dose of biological therapy 38 13.7  
Stopped all of the medications 39 14.1  
Disease activity* (Visual Analog Scale)     4.4±2.8
Complaints after treatment changes Worsened 91 32.9  
Decreased 3 1.1  
Unchanged 183 66.1  
SD: Standard deviation; * Disease activity was evaluated with a global health assessment using Visual Analog Scale, since physical examination of the cases and laboratory measurements could not be performed.